Akanda (AKAN) Competitors

$0.13
+0.03 (+29.27%)
(As of 05/16/2024 ET)

AKAN vs. SMFL, BTTX, TIVC, SCNI, HSTO, OSAP, BLPH, SPRC, SBFM, and CMRA

Should you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Smart for Life (SMFL), Better Therapeutics (BTTX), Tivic Health Systems (TIVC), Scinai Immunotherapeutics (SCNI), Histogen (HSTO), ProSomnus (OSAP), Bellerophon Therapeutics (BLPH), SciSparc (SPRC), Sunshine Biopharma (SBFM), and Comera Life Sciences (CMRA). These companies are all part of the "medical" sector.

Akanda vs.

Akanda (NASDAQ:AKAN) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

Smart for Life has higher revenue and earnings than Akanda.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akanda$2.16M0.54-$32.28MN/AN/A
Smart for Life$17.77M0.02-$29.98M-$1.12 thousand0.00

1.0% of Akanda shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 20.4% of Akanda shares are owned by company insiders. Comparatively, 31.7% of Smart for Life shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Smart for Life received 1 more outperform votes than Akanda when rated by MarketBeat users.

CompanyUnderperformOutperform
AkandaN/AN/A
Smart for LifeOutperform Votes
1
100.00%
Underperform Votes
No Votes

Akanda has a net margin of 0.00% compared to Smart for Life's net margin of -188.32%.

Company Net Margins Return on Equity Return on Assets
AkandaN/A N/A N/A
Smart for Life -188.32%N/A -75.82%

In the previous week, Smart for Life had 1 more articles in the media than Akanda. MarketBeat recorded 4 mentions for Smart for Life and 3 mentions for Akanda. Akanda's average media sentiment score of 0.56 beat Smart for Life's score of 0.54 indicating that Akanda is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Akanda
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Smart for Life
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Akanda has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Akanda
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Smart for Life beats Akanda on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AKAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AKAN vs. The Competition

MetricAkandaMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$1.17M$1.29B$5.11B$7.96B
Dividend YieldN/A2.72%37.02%3.93%
P/E RatioN/A9.42170.5718.78
Price / Sales0.549.992,310.3479.10
Price / CashN/A185.3636.0031.19
Price / Book-0.142.085.464.47
Net Income-$32.28M-$165.47M$105.07M$217.14M
7 Day PerformanceN/A0.18%1.66%1.89%
1 Month Performance29.90%6.21%3.87%5.33%
1 Year Performance-87.01%13.56%7.88%11.56%

Akanda Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
0 of 5 stars
$2.82
+4.4%
N/A-97.9%$310,000.00$17.77M0.00145Gap Down
BTTX
Better Therapeutics
1.593 of 5 stars
$0.01
flat
$6.00
+40,168.5%
-98.6%$743,000.00N/A-0.0154News Coverage
Gap Up
TIVC
Tivic Health Systems
0 of 5 stars
$0.50
+4.2%
N/A-96.3%$735,000.00$1.18M-0.019Gap Up
SCNI
Scinai Immunotherapeutics
0 of 5 stars
$0.44
-4.3%
N/AN/A$823,000.00N/A-0.1333Upcoming Earnings
Stock Split
HSTO
Histogen
0 of 5 stars
$0.20
flat
N/A-73.9%$854,000.00$3.77M-0.077Gap Up
OSAP
ProSomnus
0 of 5 stars
$0.04
+38.9%
N/AN/A$696,000.00$27.65M-0.03136News Coverage
Gap Up
BLPH
Bellerophon Therapeutics
1.293 of 5 stars
$0.06
flat
$2.00
+3,452.4%
-99.5%$689,000.00N/A-0.0718Analyst Forecast
News Coverage
SPRC
SciSparc
0 of 5 stars
$1.25
flat
N/A-91.8%$888,000.00$2.88M0.003Positive News
Gap Up
SBFM
Sunshine Biopharma
2.5103 of 5 stars
$0.90
+3.5%
$260.00
+28,804.9%
-98.4%$891,000.00$24.09M-0.0544News Coverage
Gap Up
High Trading Volume
CMRA
Comera Life Sciences
0 of 5 stars
$0.02
flat
N/A-94.9%$652,000.00$630,000.00-0.0412Gap Up

Related Companies and Tools

This page (NASDAQ:AKAN) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners